Related Experiment Video
Updated: Aug 19, 2026
A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
Published on: July 21, 2023
Systolic blood pressure does not reliably identify vasoactive status in chronic heart failure
Charles W Parrott1, Cheryl Quale, Deborah L Lewis
1Providence Hospital, Mobile, Alabama 36608, USA.
Insights
Systolic blood pressure (BP) alone is unreliable for managing chronic heart failure (CHF) medications. Impedance cardiography (ICG) measuring systemic vascular resistance index (SVRI) offers a more accurate assessment for guiding treatment.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Management of chronic heart failure (CHF) often relies on systolic blood pressure (BP) for medication titration.
- Systolic BP may not accurately reflect vasoactive status due to the influence of cardiac output.
- Impedance cardiography (ICG) is a validated noninvasive method for assessing cardiac output and systemic vascular resistance.
Purpose of the Study:
- To evaluate the relationship between systolic BP and systemic vascular resistance index (SVRI) in CHF patients.
- To determine if systolic BP reliably indicates vasoactive status in CHF.
- To explore the utility of ICG-derived SVRI in guiding CHF management.
Main Methods:
- Retrospective analysis of 615 clinic visits from 71 CHF patients.
- Measurements included oscillometric systolic BP and ICG-derived SVRI.
- Comparison of absolute values and relative changes in BP and SVRI, analyzed by BP grouping.
Main Results:
- Low correlation (R²=0.21) between systolic BP and SVRI.
- Change in systolic BP poorly predicted change in SVRI (R²=0.27).
- Significant SVRI changes occurred even with stable systolic BP; low BP did not consistently indicate low SVRI.
Conclusions:
- Systolic BP is an unreliable indicator of vasoconstriction/vasodilation in CHF.
- ICG-measured SVRI may improve the guidance of vasodilating medication therapy in CHF.
- Noninvasive hemodynamic monitoring with ICG can provide critical insights for CHF patient management.
Background:
In chronic heart failure (CHF), titration of vasodilating medications is often guided by monitoring of systolic blood pressure (BP). However, systolic BP may not indicate the patient's true vasoactive status-best approximated by systemic vascular resistance-because cardiac output is also a contributing factor. Impedance cardiography (ICG) is a validated noninvasive method of measuring cardiac output and systemic vascular resistance.
Methods:
To evaluate the relationship between systolic BP and systemic vascular resistance index (SVRI) in patients with CHF, we retrospectively evaluated the systolic BP and SVRI from 71 consecutive patients during 615 CHF clinic visits. Measurement of systolic BP was through the oscillometric method and SVRI through ICG (BioZ ICG Monitor, CardioDynamics, San Diego, CA). Absolute values and relative changes in systolic BP and SVRI were compared and characterized by systolic BP grouping.
Results:
The 71 patients were an average of 69.3 +/- 12.2 years, New York Heart Association functional class 2.52 +/- 0.6, 46.5% men, and 47.8% ischemic etiology. Frequency by systolic BP grouping was: <100 mm Hg in 67 subjects (10.9%), 100 to 119 mm Hg in 245 subjects (39.8%), and >/=120 mm Hg in 303 subjects (49.3%). The correlation (R(2) value) of systolic BP to SVRI was 0.21 (N = 615), and change in systolic BP to change in SVRI from previous visit was 0.27 (N = 547). In 138 visits in which systolic BP did not change by 5 mm Hg or more, SVRI changed by 20% or more in 41 (29.7%). In the 67 visits in which systolic BP was below 100, only 6 (9.0%) had low SVRI and 57 (85.1%) had normal SVRI. In the 245 visits with systolic BP 100 to 119, 58 (23.7%) had high SVRI.
Conclusions:
Measurement of systolic BP alone does not reliably indicate the degree of vasoconstriction or vasodilation that exists in patients with CHF. Measurement of SVRI by ICG may help guide determination of need and tolerance for vasodilating medications in CHF.
Related Concept Videos
01:17Measurement of Blood Pressure
01:29Heart Failure II: Pathophysiology
01:22Heart Failure Drugs: β-Blockers
01:28Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
01:21Sites for measuring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
01:17Pathophysiology of Heart Failure